These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5846510)

  • 1. Clinical use of a new glycine-precipitated antihemophilic fraction.
    Webster WP; Roberts HR; Thelin GM; Wagner RH; Brinkhous KM
    Am J Med Sci; 1965 Dec; 250(6):643-51. PubMed ID: 5846510
    [No Abstract]   [Full Text] [Related]  

  • 2. A new high-potency glycine-precipitated antihemophilic factor (AHF) concentrate. Treatment of classical hemophilia and hemophilia with inhibitors.
    Brinkhous KM; Shanbrom E; Roberts HR; Webster WP; Fekete L; Wagner RH
    JAMA; 1968 Aug; 205(9):613-7. PubMed ID: 5695099
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of aliphatic amino acid precipitated antihemophilic factor in therapy of hemophilia.
    Brinkhous KM; Wagner RH; Roberts HR; Webster WP
    Bibl Haematol; 1968; 29():1104-8. PubMed ID: 5700305
    [No Abstract]   [Full Text] [Related]  

  • 4. Glycine-precipitated antihemophilic factor concentrates and their clinical use.
    Wagner RH; Roberts HR; Webster WP; Shanbrom E; Brinkhous KM
    Thromb Diath Haemorrh Suppl; 1968; 35():41-8. PubMed ID: 5761073
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of glycine-precipitated antihemophilic factor during surgery in the hemophilic patient.
    Garvey MB; Tannenberg WJ; Necheles TF; Allen DM
    J Pediatr; 1968 Mar; 72(3):332-5. PubMed ID: 5639745
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preparation of antihemophilic kryoprecipitates (AHKP) from fresh plasma and its use in hemophilia A].
    Brüster H
    Monatsschr Kinderheilkd (1902); 1968 Jun; 116(6):388-90. PubMed ID: 5718328
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental prophylaxis of severe hemophilia with a factor VIII concentrate.
    Shanbrom E; Thelin GM
    JAMA; 1969 Jun; 208(10):1853-6. PubMed ID: 5818829
    [No Abstract]   [Full Text] [Related]  

  • 8. The potent antihemophilic globulin concentrate derived from a cold insoluble fraction of human plasma: characterization and further data on preparation and clinical trial.
    Hershgold EJ; Pool JG; Pappenhagen AR
    J Lab Clin Med; 1966 Jan; 67(1):23-32. PubMed ID: 5321736
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cryoprecipitation and dextran precipitation in obtaining factor VIII concentrates: results of redetecting antihemophilic globulin A in a patient].
    Kubel M; Wegner H; Liebe S
    Z Gesamte Inn Med; 1974 Mar; 29(6):236-40. PubMed ID: 4409090
    [No Abstract]   [Full Text] [Related]  

  • 10. [The cryoprecipitate, plasmatic fraction rich in antihemophilic globulin (factor VIII). Its use in the treatment of hemophilia].
    Otto-Servais M; Hugues J
    Rev Med Liege; 1969 May; 24(10):401-7. PubMed ID: 5376503
    [No Abstract]   [Full Text] [Related]  

  • 11. Human plasma and plasma fractions as sources of factor VIII (antihaemophilic factor).
    Verstraete M; Olislaegers P; Van Itterbeek H; Waumans P; Lust A
    Vox Sang; 1969 Apr; 16(4):382-97. PubMed ID: 5800592
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of hemophilia with glycine-precipitated factor 8.
    Abildgaard CF; Simone JV; Corrigan JJ; Seeler RA; Edelstein G; Vanderheiden J; Schulman I
    N Engl J Med; 1966 Sep; 275(9):471-5. PubMed ID: 5917942
    [No Abstract]   [Full Text] [Related]  

  • 13. [The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].
    Duckert F; Müller G; Meili EO
    Schweiz Med Wochenschr; 1971 Dec; 101(50):1831-8. PubMed ID: 5173501
    [No Abstract]   [Full Text] [Related]  

  • 14. The preparation of a human plasma fraction by cryoprecipitation and its use in haemophilia.
    Waumans P; Van Itterbeek R; Verstraete M
    Acta Clin Belg; 1968; 23(3):139-52. PubMed ID: 5713674
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of hemophilia A with a cryoprecipitated antihemophilic factor].
    Ollendorff P
    Ugeskr Laeger; 1969 May; 131(20):877-81. PubMed ID: 5795169
    [No Abstract]   [Full Text] [Related]  

  • 16. [Colonic resection in severe hemophilia A under the protection of antihemophilic cryoprecipitates].
    Brüster H; Ringler W; Glassner K; Riech PC; Himmelbach E
    Dtsch Med Wochenschr; 1969 Sep; 94(36):1799-802. PubMed ID: 5806910
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of cryoprecipitated factor 8.
    Simson LR; Oberman HA; Penner JA
    JAMA; 1967 Feb; 199(8):554-8. PubMed ID: 6071320
    [No Abstract]   [Full Text] [Related]  

  • 18. Antihemophilic globulin (Factor 8) activity of human fibrinogen.
    Sgouris JT; Hyndman LA; Penner JA
    Vox Sang; 1966; 11(1):116-9. PubMed ID: 5906784
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Augmenting cryoprecipitate factor VIII activity.
    Nour-Eldin F
    JAMA; 1975 Nov; 234(7):705-6. PubMed ID: 1242448
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antihemophilic cryoprecipitate from fresh plasma and its use in hemophilia A].
    Brüster H; Glassner K; Riech PC
    Dtsch Med Wochenschr; 1967 Oct; 92(41):1859-66. PubMed ID: 6057144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.